Beta-blocker Discontinuation in Heart Failure With Preserved Ejection Fraction

Part of paid clinical trials in Farmington, Connecticut.

Sponsor
UConn Health
Study ID
NCT05174351
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • beta blocker discontinuation — OTHER
    beta blocker discontinuation

Study Details

This is a prospective pilot study to evaluate changes before and 4 weeks after beta-blocker withdrawal in 30 HFpEF patients.

Key Dates

Start date
Dec 20, 2021
Status verified
Jul 2025
Primary completion
Nov 1, 2027
Completion
Nov 1, 2027

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: HFpEF patients
    HFpEF patient who are currently taking beta blockers

Primary Outcome Measure

Changes in KCCQ-23 score [ Time Frame: Baseline and after 4 weeks of beta blocker discontinuation ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UConn Health / John Dempsey HospitalFarmingtonConnecticut06030
Kai Chen, MD, PhD
[email protected]
860-679-3343

Find similar trials in Farmington, CT

By condition
Heart failure
By specialty
CardiologyHeart disease
By research site
UConn Health / John Dempsey Hospital· Farmington, CT

Related Studies